Titan Medical Inc. Retains CPHS Consulting Inc. as Investor Relations Consultant
TORONTO, ONTARIO -- (Marketwired) -- 05/29/13 -- Titan Medical Inc. ("Titan" or the "Company") (TSX VENTURE:TMD)(OTCQX:TITXF) announced today it has retained the services of CPHS Consulting Inc. ("CPHS") to provide strategic investor relations and financial communications services.
CPHS is a Canadian company headquartered in Toronto, Canada. Over the last ten years, CPHS has provided strategic communications services to Canadian and U.S. based public companies across a diverse range of industries and non-profit organizations. The Principals of CPHS are Hugh Samson, CPHS' founder, and Beverly Brooks.
The term of the contract with CPHS commenced on May 23, 2013 and expires December 31, 2013 provided that the contract may be terminated earlier upon 30 days written notice by either party. The services to be provided by CPHS include the development and implementation of an investor relations strategy, enhancements to Titan's website and investor presentation materials, ongoing communications with current and prospective investors, assistance with Titan's upcoming annual meeting of shareholders as well as timely presentations to current and prospective investors. CPHS will be paid fees of $7,000 per month for its services. Mr. Samson owns 5000 Titan Warrants, TMD.WT.A.
About CPHS Consulting Inc.
CPHS was founded by Hugh Samson as a marketing and communications consulting company, and has been engaged in a broad range of successful projects involving marketing, communications and product and business development. Beverly Brooks is an investor relations expert and economist who has advised federal government Ministers and senior executives across Canada on investor, government, stakeholder, public and media relations. She has developed investor relations strategies, managed policy, regulatory and financial issues, conducted outreach exercises to various stakeholders and arranged major events for clients in a variety of sectors including biotechnology, mining, energy, health care and telecommunications.
About Titan Medical Inc.
Titan Medical Inc. is a Canadian public company (TSX VENTURE:TMD)(OTCQX:TITXF) focused on the design and development of a robotic surgical system for application in minimally invasive surgery ("MIS"). The Company's robotic surgical system, currently under development, comprises a surgeon-controlled robotic platform that includes a 3D vision system and interactive instruments for performing MIS procedures, and a surgeon workstation that provides the surgeon with an interface to the robotic platform for controlling the interactive instruments and providing a 3D endoscopic view of inside a patient's body during MIS procedures. The robotic surgical system is being designed to expand robotic surgery into areas of surgical specialties and simple and complex procedures that are currently under-serviced, and to allow surgeons to perform procedures within small to medium size surgical spaces such as general surgery and cholecystectomy. For more information, visit the Company's website at www.titanmedicalinc.com.
Forward Looking Statements
This news release contains "forward-looking statements" which reflect the current expectations of management of the Company's future growth, results of operations, performance and business prospects and opportunities. Wherever possible, words such as "may", "would", "could", "will", "anticipate", "believe", "plan", "expect", "intend", "estimate", "potential for" and similar expressions have been used to identify these forward-looking statements. These statements reflect management's current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, without limitation, those listed in the "Risk Factors" section of the Company's Annual Information Form dated April 10, 2013 (which may be viewed at www.sedar.com). Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward looking statements prove incorrect, actual results, performance or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements.
Titan Medical Inc.
John Hargrove
Interim Chief Executive Officer
(416) 548-7522 (ext. 151)
John.Hargrove@titanmedicalinc.com
www.titanmedicalinc.com
Source: Titan Medical Inc.
Released May 29, 2013